Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-150
Closed -$11K 249
2021
Q4
$11K Buy
+150
New +$11.9K ﹤0.01% 220
2017
Q1
Sell
-5,134
Closed -$288K 123
2016
Q4
$288K Sell
5,134
-318
-6% -$18.6K 0.16% 82
2016
Q3
$325K Buy
+5,452
New +$319K 0.2% 66

Other funds holding MRK

RGT Wealth Advisors's MRK Position: Q1 2022 in Review

RGT Wealth Advisors sold out of Merck (MRK) in Q1 2022, closing a stake of 150 shares — an estimated $11K sold.

RGT Wealth Advisors first reported a position in MRK in Q3 2016 and held it in 3 quarters. The position peaked at $325K in Q3 2016. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

  • RGT Wealth Advisors reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
  • RGT Wealth Advisors sold 150 Merck shares in Q1 2022, an estimated $11K.
  • RGT Wealth Advisors first reported a position in Merck in Q3 2016 and held it in 3 quarters.
  • RGT Wealth Advisors's Merck position peaked at $325K in Q3 2016.
  • 2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on RGT Wealth Advisors's 13F filing for Q1 2022, filed 5 May 2022.